Loss to follow-up (LTFU) of clients from antiretroviral therapy (ART) has a great negative impact on the immunological benefits of ART, and increased acquired immune deficiency syndrome related morbidity and mortality. The purpose of this study was to analyze socio-demographic characteristics related to LTFU among HIV and AIDS patients in Semarang City. A case-control study was carried out at Hospitals and Primary Health Centre. Patients who did not take anti-retroviral for 3 months were defined as LTFU while those regularly take anti retro viral for 3 months became the controls. The total sample of the research were 134 respondents obtained by purposive sampling technique. Chi square and logistic regression tests were performed to analyze factors associated with LTFU. The multivariate analyses showed the most dominant factors that influence with LTFU was education level (OR = 6.27. 95% CI: 2.29, 17.09). Intervention on literacy program should be emphasized to patients who are about to start and during the ART program.
The integration of educational technology is one of the necessary ways to improve the competence of qualified graduates. This study aims to create an integration of website learning model to improve the quality of students. The Current Study Provided does not indicate the incorporation of existing websites so that students are less aware of the benefits of this lesson. The Participants of this study were lecturers, undergraduate and postgraduate students and educational practitioners throughout Indonesia using online form. Methods Data collection used is direct interview and online survey and needs analysis using waterfall method. The results obtained show the merging of learning that will lead to the needs in the industry era 4.0. This study resulted in a complete innovative learning incorporation as required by Policy Makers.
Background: Human Immuno-Deficiency Virus (HIV) continues to be a major global public health issue. In 2016, an estimated 36.7 million people were living with HIV (including 1.8 million children)-with a global HIV prevalence of 0.8% among adults. Despite the recent declines in global HIV/AIDS mortality, today, HIV/AIDS remains one of the leading global causes of both mortality and burden. This study aimed to estimate the effect of smoking on survival among HIV/AIDS patients in Kedu, Central Java. Subjects and Methods: This was a cohort study conducted at Kedu, Central Java. A sample of 152 HIV patients was selected for this study. The dependent variable was death. The independent variable was smoking. HIV data were taken from medical record. The other data were collected by questionnaire. The data were analyzed by a Cox Proportional Hazard Model. Results: Mean age of the sample was 33 years, 69.7% were male, 53.3% had high education, 69.8% were smoker, and 10.5% died. The risk of mortality increased with smoking (HR=2.82; 95% CI= 1.05 to 7.56). Conclusion: Smoking increases the risk of dying among patients of HIV/ AIDS.
among participants of Methadone Maintenance Treatment (MMT) showed that respondents who had positive drop-out among respondents who had good attitudes was 98.0% higher than respondents who had a bad attitude of 57.9%. Based on the results of the multivariate analysis, attitudes toward HIV/AIDS transmission through the use of syringes obtained OR=20.091, this meant that a good attitudes toward HIV/AIDS transmission through the use of syringes allowed respondents to have positive drop-out 20.091 times compared to bad attitudes. There was a correlation between respondents' attitudes toward HIV/AIDS transmission through the use of syringes and the type of drop-out among participants of Methadone Maintenance Treatment (MMT) (p-value=0.000).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.